NAVB Navidea Biopharmaceuticals Inc

Navidea Biopharmaceuticals Inc is a biotechnology company engaged in precision medicine. Its products are designed to assist in the identification of undetected diseases and develop treatment for cancer, autoimmune conditions, and inflammatory diseases.

$1.90
As of 04/09/2021     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  11/10/1992
Outstanding shares:  28,567,298
Average volume:  303,181
Market cap:   $54,277,866
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    63937X202
ISIN:        US63937X2027
Sedol:      BJHDL45
Valuation   (See tab for details)
PE ratio:   -4.77
PB ratio:   4.43
PS ratio:   59.32
Return on equity:   -600.59%
Net income %:   -863.53%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy